lorazepam has been researched along with humulene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, SK; Chakrabarti, A; Glover, V; Sandler, M | 1 |
| Doig, K; Eliasziw, M; Kiss, ZH; Ranawaya, R; Suchowersky, O | 1 |
| Roberts, C; Smith, DL | 1 |
| Gauthier, T; Keopple, D; Prakash, PB; Vardis, R | 1 |
1 trial(s) available for lorazepam and humulene
| Article | Year |
|---|---|
The Canadian multicenter trial of pallidal deep brain stimulation for cervical dystonia: preliminary results in three patients.
Topics: Amitriptyline; Botulinum Toxins; Cannabis; Combined Modality Therapy; Drug Therapy, Combination; Dysarthria; Electric Stimulation Therapy; Electrodes, Implanted; Feasibility Studies; Female; Globus Pallidus; Humans; Lactones; Lorazepam; Magnetic Resonance Imaging; Male; Middle Aged; Propranolol; Rhizotomy; Sulfones; Torticollis; Treatment Outcome | 2004 |
3 other study(ies) available for lorazepam and humulene
| Article | Year |
|---|---|
Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety.
Topics: Animals; Anxiety; Brain; Brain Chemistry; Cannabis; Ethanol; Isatin; Isoenzymes; Lorazepam; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morphine; Nicotine; Ondansetron; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1995 |
Synthetic marijuana use and development of catatonia in a 17-year-old male.
Topics: Adolescent; Cannabinoids; Cannabis; Catatonia; Designer Drugs; Electroconvulsive Therapy; Humans; Illicit Drugs; Lorazepam; Male; Psychoses, Substance-Induced; Recurrence | 2014 |
Cannabis-Induced Catatonia in a 15-Year-Old Male: A Case Report.
Topics: Adolescent; Cannabis; Catatonia; Humans; Lorazepam; Male; Prognosis | 2023 |